Literature DB >> 26676661

Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.

Nikolaos Papanas1, Dan Ziegler2.   

Abstract

Distal symmetric sensorimotor polyneuropathy (DSPN) is the most common neurological manifestation in diabetes. Major risk factors of DSPN include diabetes duration, hyperglycemia, and age, followed by prediabetes, hypertension, dyslipidemia, and obesity. Height, smoking, insulin resistance, hypoinsulinemia, and others represent an additional risk. Importantly, hyperglycemia, hypertension, dyslipidemia, obesity, and smoking are modifiable. Stringent glycemic control has been shown to be effective in type 1, but not to the same extent in type 2 diabetes. Antilipidemic treatment, especially with fenofibrate, and multi-factorial intervention have produced encouraging results, but more experience is necessary. The major comorbidities of DSPN are depression, autonomic neuropathy, peripheral arterial disease, cardiovascular disease, nephropathy, retinopathy, and medial arterial calcification. Knowledge of risk factors and comorbidities has the potential to enrich the therapeutic strategy in clinical practice as part of the overall medical care for patients with neuropathy. This article provides an updated overview of DSPN risk factors and comorbidities.

Entities:  

Mesh:

Year:  2015        PMID: 26676661      PMCID: PMC5397983          DOI: 10.1900/RDS.2015.12.48

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  154 in total

1.  Adults with diabetic peripheral neuropathy exhibit impairments in multitasking and other executive functions.

Authors:  Jason L Rucker; Stephen D Jernigan; Joan M McDowd; Patricia M Kluding
Journal:  J Neurol Phys Ther       Date:  2014-04       Impact factor: 3.649

Review 2.  Current options and perspectives in the treatment of diabetic neuropathy.

Authors:  Tamás Várkonyi; Zsuzsanna Putz; Katalin Keresztes; Tímea Martos; Csaba Lengyel; Alin Stirban; György Jermendy; Peter Kempler
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 3.  New vistas in the diagnosis of diabetic polyneuropathy.

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Endocrine       Date:  2014-05-17       Impact factor: 3.633

4.  Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study.

Authors:  M L Sands; S M Shetterly; G M Franklin; R F Hamman
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

5.  The impact of peripheral neuropathy and cognitive decrements on gait in older adults with type 2 diabetes mellitus.

Authors:  Tine Roman de Mettelinge; Kim Delbaere; Patrick Calders; Tineke Gysel; Nele Van Den Noortgate; Dirk Cambier
Journal:  Arch Phys Med Rehabil       Date:  2013-02-04       Impact factor: 3.966

6.  Effect of Urtica dioica on memory dysfunction and hypoalgesia in an experimental model of diabetic neuropathy.

Authors:  Sita Sharan Patel; M Udayabanu
Journal:  Neurosci Lett       Date:  2013-07-31       Impact factor: 3.046

7.  Ankle-brachial index: a surrogate marker of microvascular complications in type 2 diabetes mellitus?

Authors:  N Papanas; G Symeonidis; G Mavridis; G S Georgiadis; T T Papas; M K Lazarides; E Maltezos
Journal:  Int Angiol       Date:  2007-09       Impact factor: 2.789

Review 8.  The role of physical activity and psychological coping strategies in the management of painful diabetic neuropathy--A systematic review of the literature.

Authors:  Ben Davies; Fiona Cramp; Jeremy Gauntlett-Gilbert; David Wynick; Candida S McCabe
Journal:  Physiotherapy       Date:  2015-04-22       Impact factor: 3.358

9.  Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study.

Authors:  Morten Charles; Niels Ejskjaer; Daniel R Witte; Knut Borch-Johnsen; Torsten Lauritzen; Annelli Sandbaek
Journal:  Diabetes Care       Date:  2011-08-04       Impact factor: 19.112

10.  Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden.

Authors:  Lars Kärvestedt; Eva Mårtensson; Valdemar Grill; Stig Elofsson; Gunvor von Wendt; Anders Hamsten; Kerstin Brismar
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 17.152

View more
  48 in total

1.  Use of graded Semmes Weinstein monofilament testing for ascertaining peripheral neuropathy in people with and without diabetes.

Authors:  Muideen T Olaiya; Robert L Hanson; Karen G Kavena; Madhumita Sinha; Dawn Clary; Mark B Horton; Robert G Nelson; William C Knowler
Journal:  Diabetes Res Clin Pract       Date:  2019-03-25       Impact factor: 5.602

Review 2.  Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications.

Authors:  John N Stabley; Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-22       Impact factor: 8.311

3.  Detecting time-evolving phenotypic topics via tensor factorization on electronic health records: Cardiovascular disease case study.

Authors:  Juan Zhao; Yun Zhang; David J Schlueter; Patrick Wu; Vern Eric Kerchberger; S Trent Rosenbloom; Quinn S Wells; QiPing Feng; Joshua C Denny; Wei-Qi Wei
Journal:  J Biomed Inform       Date:  2019-08-22       Impact factor: 6.317

4.  Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy.

Authors:  Yogendranathsing Unmar; Mohammad Ishraq Zafar; Feng Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

5.  Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study.

Authors:  Chi-Sheng Wang; Yen-Wei Pai; Ching-Heng Lin; I-Te Lee; Ming-Hong Chang
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

Review 6.  Gastroparesis.

Authors:  Michael Camilleri; Victor Chedid; Alexander C Ford; Ken Haruma; Michael Horowitz; Karen L Jones; Phillip A Low; Seon-Young Park; Henry P Parkman; Vincenzo Stanghellini
Journal:  Nat Rev Dis Primers       Date:  2018-11-01       Impact factor: 52.329

7.  Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.

Authors:  Ting Bao; Coby Basal; Christina Seluzicki; Susan Q Li; Andrew D Seidman; Jun J Mao
Journal:  Breast Cancer Res Treat       Date:  2016-08-10       Impact factor: 4.872

Review 8.  Polyneuropathies.

Authors:  Claudia Sommer; Christian Geber; Peter Young; Raimund Forst; Frank Birklein; Benedikt Schoser
Journal:  Dtsch Arztebl Int       Date:  2018-02-09       Impact factor: 5.594

9.  Diabetic Neuropathy Prevalence and Its Associated Risk Factors in Two Representative Groups of Type 1 and Type 2 Diabetes Mellitus Patients from Bihor County.

Authors:  Bondar Andrei Cristian; Popa Amorin Remus
Journal:  Maedica (Bucur)       Date:  2018-09

Review 10.  Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review).

Authors:  Andrei Bondar; Amorin Remus Popa; Nikolaos Papanas; Mihaela Popoviciu; Cosmin Mihai Vesa; Monica Sabau; Cristian Daina; Roxana Adriana Stoica; Niki Katsiki; Anca Pantea Stoian
Journal:  Exp Ther Med       Date:  2021-04-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.